RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

EMBO Journal

Volumn 16, Issue 5, 1997, Pages 1045-1055

  Durand, Bénédicte ^a,b   Sperisen, Peter ^b   Emery, Patrick ^b   Barras, Emmanuèle ^b   Zufferey, Madeleine ^b   Mach, Bernard ^b   Reith, Walter ^b  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Bare lymphocyte syndrome; Gene expression; Human disease gene; MHC class II deficiency; RRX proteins

Indexed keywords

DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN SUBUNIT;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; DNA TRANSFECTION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; STOP CODON;

EID: 0031055891     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.5.1045     Document Type: Article

References (58)

1. Accolla, R.S. (1983) Human B cell variants immunoselected against a single Ia antigen subset have lost expression in several Ia antigen subsets. J. Exp. Med., 157, 1053-1058.
2. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, C.J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
3. Bairoch, A. (1992) Prosite - A dictionary of sites and patterns in proteins. Nucleic Acids Res., 20, 2013-2018.
4. Benacerraf, B. (1981) Role of MHC gene products in immune regulation. Science, 212, 1229-1238.
5. Benichou, B. and Strominger, J.L. (1991) Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl Acad. Sci. USA, 88, 4285-4288.
6. Benoist, C. and Mathis, C. (1990) Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol., 8, 681-715.
7. Bottazzo, G.F., Todd, I., Mirakian, R., Belfiore, A. and Pujol-Borrell, R. (1986) Organ-specific autoimmunity: a 1986 overview. Immunol. Rev., 94, 137-169.
8. Calman, A.F. and Peterlin, B.M. (1987) Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol., 139, 2489-2495.
9. Casper, J.T., Ash, R.A., Kirchner, P., Hunter, J.B., Havens, P.L. and Chusid, M.J. (1990) Successful treatment of an HLA-deficient SCID ('bare lymphocyte syndrome') patient with an unrelated bone marrow transplant. J. Pediatr., 116, 262-265.
10. Chang, C.-H., Fontes, J.D., Peterlin, M. and Flavell, R.A. (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med., 180, 1367-1374.
11. Chang, C.-H., Hong, S.-C. Hughes, C.C.W., Janeway, C.A.J. and Flavell, R.A. (1996) CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol., 17, 1515-1518.
12. Charron, C.J. and McDevitt, H.O. (1979) Analysis of HLA-D region-associated molecules with monoclonal antibody. Proc. Natl Acad. Sci. USA, 76, 6567-6571.
13. Chin, K., Mao, C. Skinner, C. Riley, J.L., Wright, K.L., Moreno, C.S., Stark, G.R., Boss, J.M. and Ting, J.P. (1994) Molecular analysis of G1B and G3A IFN-gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity, 1, 687-697.
14. Cormack, B.P. Strubin, M., Ponticelli, A.S. and Struhl, K. (1991) Functional differences between yeast and human TFIID are localized to the highly conserved region. Cell, 65, 341-348.
15. de Preval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C. and Mach, B. (1985) A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature, 318, 291-293.
16. Dingwall, C. and Laskey, R.A. (1991) Nuclear Targeting Sequences - a consensus? Trends Biochem. Sci., 16, 478-481.
17. Durand, B., Kobr, M., Reith, W. and Mach, B. (1994) Functional complementation of MHC class II regulatory mutants by the purified X box binding protein RFX. Mol. Cell. Biol., 14, 6839-6847.
18. Emery, P., Durand, B., Mach, B. and Reith, W. (1996a) RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res., 24, 803-807.
19. Emery, P., Strubin, M., Hofmann, K., Bucher, P., Mach, B. and Reith, W. (1996b) A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specifity. Mol. Cell. Biol., 16, 4486-4494.
20. Gladstone, P. and Pious, C. (1978) Stable variants affecting B cell alloantigens in human lymphoid cells. Nature, 271, 459-461.
21. Glimcher, L.H. and Kara, C.J. (1992) Sequences and factors: A guide to MHC class-II transcription. Annu. Rev. Immunol., 10, 13-49.
22. Griscelli, C., Lisowska-Grospierre, B. and Mach, B. (1993) Combined immunodeficiency with defective expression in MHC class II genes. In Rosen, F.S. and Seligman, M. (eds), Immunodeficiencies. Harwood Academic Publishers, Chur, Switzerland, pp. 141-154.
23. Hasegawa, S.L., Riley, J.L., Sloan III, J.H. and Boss, J.M. (1993) Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells. J. Immunol., 150, 1781-1793.
24. Herrero Sanchez, C., Reith, W., Silacci, P. and Mach, B. (1992) The DNA binding defect observed in MHC class II regulatory mutants concerns only one member of a family of complexes binding to the X box of class II promoters. Mol. Cell. Biol., 12, 4076-4083.
25. Hume, C.R. and Lee, J.S. (1989) Congenital Immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol., 26, 288-309.
26. Hume, C.R., Shookster, L.A., Collins, N., O'Reilly, R. and Lee, J.S. (1989) Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Hum. Immunol., 25, 1-11.
27. Janeway, C. A. et al. (1984) Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol. Today, 5, 55-60.
28. Kara, C.J. and Glimcher, L.H. (1991) In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science, 252, 709-712.
29. Kara, C.J. and Glimcher, L.H. (1993) Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics, 37, 227-230.
30. Kozak, M. (1989) The scanning model for translation - an update. J. Cell Biol., 108, 229-241.
31. Lennon, G., Auffray, C., Polymeropoulos, M. and Soares, M.B. (1996) The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics, 33, 151-152.
32. Levine, F. and Pious, C. (1984) Revertants from the HLA class II regulatory mutant 6.1.6.: implications for the regulation of Ia gene expression. J. Immunol., 132, 959-962.
33. Lisowska-Grospierre, B., Fondaneche, M.C., Rols, M.P., Griscelli, C. and Fischer, A. (1994) Two complementation groups account for most cases of inherited MHC class II deficiency. Hum. Mol. Genet., 3, 953-958.
34. Mach, B., Steimle, V., Martinez-Soria, E. and Reith, W. (1996) Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol., 14, 301-331.
35. Miller, J.H. (1983) Mutational specificity in bacteria. Annu. Rev. Genet., 17, 215-238.
36. Moreno, C.S., Emery, P., West, J.E., Durand, B., Reith, W., Mach, B. and Boss, J.M. (1995) Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol., 155, 4313-4321.
37. Reith, W., Satola, S., Herrero Sanchez, C., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M.R. and Mach, B. (1988) Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell, 53, 897-906.
38. Reith, W., Kobr, M., Emery, P., Durand, B., Siegrist, C.A. and Mach, B. (1994a) Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem., 269, 20020-20025.
39. Reith, W., Siegrist, C.A., Durand, B., Barras, E. and Mach, B. (1994b) Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl Acad. Sci. USA, 91, 554-558.
40. Reith, W., Steimle, V. and Mach, B. (1995) Molecular defects in the Bare Lymphocyte Syndrome and the regulation of MHC class II genes. Immunol. Today, 16, 539-546.
41. Reith, W., Steimle, V., Lisowska-Grospierre, B., Fischer, A. and Mach, B. (1997) Molecular basis of major histocompatibility class II deficiency. In Ochs, H., Puck, J. and Smith, E. (eds), Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. Oxford University Press, New York, in press.
42. Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A. and Boss, J.M. (1995) Activation of class II MHC genes requires both the X box and the class II transactivator (CIITA). Immunity, 2, 533-543.
43. Rosenfeld, J., Capdevielle, J., Guillemot, J.C. and Ferrara, P. (1992) In-gel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis. Anal. Biochem., 203, 173-179.
44. Seidl, C., Saraiya, C., Osterweil, Z., Fu, Y.P. and Lee, J.S. (1992) Genetic complexity of regulatory mutants defective for HLA class-II geneexpression. J. Immunol., 148, 1576-1584.
45. Sikorski, R.S. and Hieter, P. (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics, 122, 19-27.
46. Silacci, P., Mottet, A., Steimle, V., Reith, W. and Mach, B. (1994) Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med., 180, 1329-1336.
47. Steimle, V., Otten, L.A., Zufferey, M. and Mach, B. (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell, 75, 135-146.
48. Steimle, V., Siegrist, C., Mottet, A., Lisowska-Grospierre, B. and Mach, B. (1994) Regulation of MHC class II expression by Interferon-gamma mediated by the transactivator gene CIITA. Science, 265, 106-109.
49. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M.R., Mach, B. and Reith, W. (1995) A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (Bare Lymphocyte Syndrome). Genes Dev., 9, 1021-1032.
50. Stimac, E., Urieli-Shoval, S., Kempin, S. and Pious, C. (1991) Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients. J. Immunol., 146, 4398-4405.
51. Strubin, M., Newell, J.W. and Matthias, P. (1995) OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with Octamer-binding proteins. Cell, 80, 497-506.
52. Touraine, J.L. and Bétuel, H. (1981) Immunodeficiency diseases and expression of HLA antigens. Hum. Immunol., 2, 147-153.
53. Touraine, J.L., Bétuel, H. and Souillet, G. (1978) Combined immunodeficiency disease associated with absence of cell surface HLA A and B antigen. J. Pediatr., 93, 47-51.
54. Touraine, J.L., Marseglia, G.L., Betuel, H., Souillet, G. and Gebuhrer, L. (1992) The bare lymphocyte syndrome. Bone Marrow Transplant, 9 (Suppl. 1), 54-56.
55. Triezenberg, S.J., Kingsbury, R.C. and McKnight, S.L. (1988) Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev., 2, 718-729.
56. Watson, A.J., Bach, F.H., Demars, R. and Trowbridge, I.S. (1983) Detection of a novel human class II HLA antigen. Nature, 304, 358-361.
57. Zhou, H. and Glimcher, L.H. (1995) Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity, 2, 545-553.
58. Ziegler, A., Gotz, H., Heinig, J., Muller, C., Thinnes, F.P., Uchanska-Ziegler, B. and Wernet, P. (1986) Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies Tü22, Tü34, T̈35, T̈36, Tü37, T̈39, T̈43, T̈58, and Yd1/63.Hlk directed against human HLA class II antigens. Immunobiology, 171, 77-92.